Murat Kalayoglu

Insider Reports History

Entity
Individual
Location
C/O Cartesian Therapeutics, Inc., 704 Quince Orchard Rd, Gaithersburg, MD
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Murat Kalayoglu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Murat Kalayoglu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. Director, 10%+ Owner Common Stock 4.56M $15M $3.30 Jan 2, 2025 by trust
Cartesian Therapeutics, Inc. Director, 10%+ Owner Common Stock 509K $1.68M $3.30 Jan 2, 2025 Direct
Cartesian Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 7.8K $6.16K $0.79 Jan 2, 2025 Direct
Cartesian Therapeutics, Inc. Director, 10%+ Owner Series A Non-Voting Convertible Preferred Stock 56.4K Oct 11, 2024 by trust

Insider Reports Filed by Murat Kalayoglu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNAC Cartesian Therapeutics, Inc. Jan 2, 2025 2 $0 4 Jan 6, 2025 Director, 10%+ Owner
RNAC Cartesian Therapeutics, Inc. Oct 11, 2024 2 $0 4 Oct 15, 2024 Director, 10%+ Owner
RNAC Cartesian Therapeutics, Inc. Apr 8, 2024 4 $0 4 Apr 10, 2024 Director, 10%+ Owner
RNAC Cartesian Therapeutics, Inc. Jan 2, 2024 2 $0 4 Jan 4, 2024 Director, 10%+ Owner
SELB Cartesian Therapeutics, Inc. Nov 13, 2023 5 $155M 4 Nov 15, 2023 Director, 10%+ Owner
SELB Cartesian Therapeutics, Inc. Nov 13, 2023 0 $0 3 Nov 15, 2023 Director, 10%+ Owner